Impact of Ixekizumab on Work Productivity in Patients With Ankylosing Spondylitis: Results From the COAST-V and COAST-W Trials at 52 Weeks
mediaposted on 2020-08-13, 11:10 authored by Helena Marzo-Ortega, Philip J. Mease, Proton Rahman, Victoria Navarro-Compán, Vibeke Strand, Maxime Dougados, Bernard Combe, James Cheng-Chung Wei, Xenofon Baraliakos, Theresa Hunter, David Sandoval, Xiaoqi Li, Baojin Zhu, Louis Bessette, Atul Deodhar
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.